• Profile
Close

Methicillin-resistant Staphylococcal aureus keratitis: Initial treatment, risk factors, clinical features, and treatment outcomes

American Journal of Ophthalmology Mar 26, 2020

Durrani AF, Atta S, Bhat A, et al. - Researchers examined cases of methicillin-resistant Staphylococcal aureus (MRSA) keratitis for the clinical characteristics, management choices, and outcomes. They assessed retrospective interventional case series of 52 culture-proven (52 eyes) cases of MRSA keratitis diagnosed and treated at the University of Pittsburgh Medical Center. The patients had mean age of 66.6±19.2 years with median follow-up time of 147 days. A history of ocular surgery (62.5%), topical corticosteroid use (35.4%), and dry eye syndrome (37.5%) were the most prevalent risk factors. They noted a high burden of systemic disease (95.8%). MRSA causes fulminant keratitis that often require surgical management and has poor visual acuity outcomes. Comparable outcomes were achieved in patients treated with fluoroquinolones in this study vs those treated with fortified vancomycin, however, higher tendency for more severe ulcers at presentation was observed in those treated with fortified vancomycin.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay